Heart failure-induced diaphragm myopathy

Cellular Physiology and Biochemistry

Volumn 34, Issue 2, 2014, Pages 333-345

  Lima, Aline Regina Ruiz ^a   Martinez, Paula Felippe ^b   Damatto, Ricardo Luiz ^a   Cezar, Marcelo Diarcadia Mariano ^a   Guizoni, Daniele Mendes ^a   Bonomo, Camila ^a   Oliveira, Silvio Assis ^b   Dal Pai Silva, Maeli ^a   Zornoff, Leonardo Antonio Mamede ^a   Okoshi, Katashi ^a   Okoshi, Marina Politi ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Echocardiography; MAPK; Myocardial infarction; Myogenic regulatory factors; Myosin heavy chain isoforms; Skeletal muscle

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; MYOGENIC FACTOR; MYOGENIC REGULATORY FACTOR 4; MYOSIN HEAVY CHAIN; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIAPHRAGM DISEASE; DISEASE SEVERITY; ELECTROPHORESIS; ENZYME PHOSPHORYLATION; EUTHANASIA; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; LUNG CONGESTION; LUNG WEIGHT; MALE; MYOPATHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TRANSTHORACIC ECHOCARDIOGRAPHY; CARDIOVASCULAR PARAMETERS; CORRELATIONAL STUDY; DIAPHRAGM MUSCLE; DIAPHRAGM MYOPATHY; DIASTOLIC DYSFUNCTION; DIASTOLIC LEFT VENTRICULAR DYSFUNCTION; LEFT ATRIAL DIAMETER TO BODY WEIGHT RATIO; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; PROTEIN PHOSPHORYLATION; SHAM PROCEDURE; ANIMAL; BLOOD; COMPLICATION; DIAPHRAGM; ECHOCARDIOGRAPHY; ECHOGRAPHY; MUSCULAR DISEASES; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WISTAR RAT;

RATTUS;

ANIMALS; BLOTTING, WESTERN; DIAPHRAGM; ECHOCARDIOGRAPHY; HEART FAILURE; INTERLEUKIN-6; MALE; MUSCULAR DISEASES; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904525197     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000363003     Document Type: Article

References (62)

1. Harrington D, Anker SD, Coats AJS: Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur Heart J 2001;22:392-399.
2. Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M, Teixeira MM, Hellewell PG, Hooper J, Poole-Wilson PA, Coats AJS: Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20:683-693.
3. Strassburg S, Springer J, Anker SD: Muscle wasting in cardiac cachexia. Intern J Biochem Cell Biol 2005;37:1938-1947.
4. Tikunov BA, Mancini D, Levine S: Changes in myofibrillar protein composition of human diaphragm elicited by congestive heart failure. J Mol Cell Cardiol 1996;28:2537-2541.
5. MacFarlane NG, Darnley GM, Smith GL: Cellular basis for contractile dysfunction in the diaphragm from a rabbit infarct model of heart failure. Am J Physiol Cell Physiol 2000;278:C739-C746.
6. Lima ARR, Martinez PF, Okoshi K, Guizoni DM, Zornoff LAM, Campos DHS, Oliveira Jr SA, Bonomo C, Dal Pai-Silva M, Okoshi MP: Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure. Int J Exp Path 2010;91:54-62.
7. Von Haehling S, Steinbeck L, Doehner W, Springer J, Anker SD: Muscle wasting in heart failure: An overview. Int J Biochem Cell Biol 2013;45:2257-2265.
8. van Hees HWH, van der Heijden HFM, Hafmans T, Ennen L, Heunks LMA, Verheugt FWA, Dekhuijzen PNR: Impaired isotonic contractility and structural abnormalities in the diaphragm of congestive heart failure rats. Int J Cardiol 2008;128:326-335.
9. Lindsay DC, Lovegrove CA, Dunn MJ, Bennett JG, Pepper JR, Yacoub MH, Poole-Wilson PA: Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J 1996, 17:1239-1250.
10. De Sousa E, Veksler V, Bigard X, Mateo P, Serrurier B, Ventura-Clapier R: Dual influence of disease and increased load on diaphragm muscle in heart failure. J Mol Cell Cardiol 2001;33:699-710.
11. van Hees HWH, van der Heijden HFM, Ottenheijm CA, Heunks LMA, Pigmans CJ, Verheugt FWA, Brouwer RM, Dekhuijzen PNR: Diaphragm single-fiber weakness and loss of myosin in congestive heart failure rats. Am J Physiol Heart Circ Physiol 2007;293:H819-H828.
12. Lopes FS, Carvalho RF, Campos GER, Sugizaki MM, Padovani CR, Nogueira CR, Cicogna AC, Dal Pai-Silva M: Down-regulation of MyoD gene expression in rat diaphragm muscle with heart failure. Int J Exp Path 2008;89:216-22.
13. Mancini DM, Henson D, LaManca J, Levine S: Evidence of reduced respiratory muscle endurance in patients with heart failure. J Am Coll Cardiol 1994;24:972-81.
14. Ambrosino N, Opasich C, Crotti P, Cobelli F, Tavazzi L, Rampulla C: Breathing pattern, ventilatory drive and respiratory muscle strenght in patients with chronic heart failure. Eur Respir J 1994;7:17-22.
15. Habedank D, Meyer FJ, Hetzer R, Anker SD, Ewert R: Relation of respiratory muscle strenght, cachexia and survival in severe heart failure. J Cachexia Sarcopenia Muscle 2013;4:277-285.
16. Marco E, Ramirez-Sarmineto AL, Coloma A, Sartor M, Comin-Colet J, Vila J, Enjuanes C, Bruguera J, Escalada F, Gea J, Orozco-Levi M: High-intensity vs. sham inspiratory muscle training in patients with chronic heart failure: a prospective randomized trial. Eur J Heart Fail 2013;15:892-901.
17. Dall'Ago P, Chiappa GRS, Guths H, Stein R, Ribeiro JP: Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness. A randomized trial. J Am Coll Cardiol 2006;47:757-763.
18. Tikunov B, Levine S, Mancini D: Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle. Circulation 1997;95:910-916.
19. Howell S, Maarek JMI, Fournier M, Sullivan K, Zhan WZ, Sieck GC: Congestive heart failure: differential adaptation of the diaphragm and latissimus dorsi. J Appl Physiol 1995;79:389-397.
20. Shi H, Scheffler JM, Pleitner JM, Zeng L, Park S, Hannon KM, Grant AL, Gerrard DE: Modulation of skeletal muscle fiber type by mitogen activated protein kinase signaling. FASEB J 2008;22:2990-3000.
21. Shi H, Scheffler JM, Zeng C, Pleitner JM, Hannon KM, Grant AL: Mitogen-activated protein kinase signaling is necessary for the maintenance of skeletal muscle mass. Am J Physiol Cell Physiol 2009;296:C1040-C1048.
22. Strle K, Broussard SR, McCusker RH, Shen W-H, LeCleir JM, Johnson RW, Freund GG, Dantzer R, Kelley KW: C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts. Endocrinology 2006;147:4363-4373.
23. Sigala I, Zacharatos P, Toumpanakis D, Michailidou T, Noussia O, Theocharis S, Roussos C, Papapetropoulos A, Vassilakopoulos T: MAPKs and NF-kB differentially regulate cytokine expression in the diaphragm in response to resistive breathing: the role of oxidative stress Am J Physiol Regul Integr Comp Physiol 2011;300:R1152-R1162.
24. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC: Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 2000;275:11706-11712.
25. Chen S-E, Jin B, Li Y-P: TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol 2007;292:C1660-1671.
26. Lluis F, Perdiguero E, Nebreda AR, Cánoves-Muñoz P: Regulation of skeletal mucsle gene expression by p38 MAP kinase. Trends Cell Bilogy 2006;16:36-44.
27. Hughes SM, Taylor JM, Tapscott SJ, Gurley CM, Carter WJ, Peterson CA: Selective accumulation of MyoD and myogenin mRNAs in fast and slow muscle is controlled by innervation and hormones. Development 1993;118:1137-1147.
28. Hughes SM, Chi MM-Y, Lowry OH, Gundersen K: Myogenin induces a shift of enzyme activity from glycolytic to oxidative metabolism in muscles of transgenic mice. J Cell Biol 1999;145:633-642.
29. Martinez PF, Okoshi K, Zornoff LAM, Carvalho RF, Oliveira Jr SA, Lima ARR, Campos DHS, Damatto RL, Nogueira CR, Dal Pai-Silva M, Okoshi MP: Chronic heart failure-induced skeletal muscle atrophy, necrosis, and myogenic regulatory factors changes. Med Sci Monit 2010;16:BR374-383.
30. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, Guttridge DC: Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004;114:370-378.
31. Carvalho RF, Cicogna AC, Campos GER, Assis JMF, Padovani CR, Okoshi MP, Dal Pai-Silva M: Myosin heavy chain expression and atrophy in rat skeletal muscle during transition from cardiac hypertrophy to heart failure. Int J Exp Path 2003;84:201-206.
32. Coirault C, Langeron O, Lambert F, Blanc F, Lerebours G, Claude N, Riou B, Chemla D, Lecarpentier Y: Impaired skeletal muscle performance in the early stage of cardiac pressure overload in rabbits: beneficial effects of angiotensin-converting enzyme inhibition. J Pharmacol Exp Ther 1999;291:70-75.
33. Minicucci MF, Azevedo PS, Martinez PF, Lima ARR, Bonomo C, Guizoni DM, Polegato BF, Okoshi MP, Okoshi K, Matsubara BB, Paiva SAR, Zornoff LAM: Critical infarct size to induce ventricular remodeling, cardiac dysfunction and heart failure in rats. Int J Cardiol 2011;51:242-243.
34. Martinez PF, Okoshi K, Zornoff LAM, Oliveira Jr SA, Campos DHS, Lima ARR, Damatto RL, Cezar MDM, Bonomo C, Guizoni DM, Padovani CR, Cicogna AC, Okoshi MP: Echocardiographic detection of congestive heart failure in postinfarction rats. J Appl Physiol 2011;111:543-551.
35. Cicogna AC, Robinson KG, Conrad CH, Singh K, Squire R, Okoshi MP, Bing OHL: Direct effects of colchicine on myocardial function. Studies in hypertrophied and failing spontaneously hypertensive rats. Hypertension 1999;33:60-65.
36. Damatto RL, Martinez PF, Lima AR, Cezar MD, Campos DH, Oliveira Junior SA, Guizoni DM, Bonomo C, Nakatani BT, Dal Pai Silva M, Carvalho RF, Okoshi K, Okoshi MP: Heart failure-induced skeletal myopathy in spontaneously hypertensive rats. Int J Cardiol 2013;167:698-703.
37. Okoshi K, Ribeiro HB, Okoshi MP, Matsubara BB, Gonçalves G, Barros R, Cicogna AC: Improved systolic ventricular function with normal myocardial mechanics in compensated cardiac hypertrophy. Jpn Heart J 2004;45:647-656.
38. Okoshi K, Fioretto JR, Okoshi MP, Cicogna AC, Aragon FF, Matsubara LS, Matsubara BB: Food restriction induces in vivo ventricular dysfunction in spontaneously hypertensive rats without impairment of in vitro myocardial contractility. Braz J Med Biol Res 2004;37:607-613.
39. Sugizaki MM, Carvalho RF, Aragon FF, Padovani CR, Okoshi K, Okoshi MP, Zanati SG, Pai-Silva MD, Novelli EL, Cicogna AC: Myocardial dysfunction induced by food restriction is related to morphological damage in normotensive middle-aged rats. J Biomed Sci 2005;12:641-649.
40. Nascimento AF, Luvizotto RA, Leopoldo AS, Lima-Leopoldo AP, Seiva FR, Justulin LAJ, Silva MD, Okoshi K, Wang XD, Cicogna AC: Long-term high-fat diet-induced obesity decreases the cardiac leptin receptor withou apparent lipotoxicity. Life Sci 2011;88:1031-1038.
41. Rosa CM, Xavier NP, Campos DH, Fernandes AA, Cezar MD, Martinez PF, Cicogna AC, Gimenes C, Gimenes R, Okoshi MP, Okoshi K: Diabetes mellitus activated fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats. Cardiovasc Diabetol 2013;12:152.
42. Cezar MDM, Damatto RL, Martinez PF, Lima ARR, Campos DHS, Rosa CM, Guizoni DM, Bonomo C, Cicogna AC, Gimenes R, Pagan LU, Okoshi MP, Okoshi K: Aldosterone blockade reduces mortality without changing cardiac remodeling in spontaneously hypertensive rats. Cell Physiol Biochem 2013;32:1275-1287.
43. Oliveira Jr SA, Dal Pai Silva M, Martinez PF, Lima-Leopoldo AP, Campos DH, Leopoldo AS, Okoshi MP, Okoshi K, Padovani CR, Cicogna AC: Diet-induced obesity causes metabolic, endocrine and cardiac alterations in spontaneously hypertensive rats. Med Sci Monit 2010;16:BR367-BR373.
44. Yan X, Schuldt AJ, Price RL, Amende I, Liu FF, Okoshi K, Ho KK, Pope AJ, Borg TK, Lorell BH, Morgan JP: Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes. Am J Physiol Heart Circ Physiol 2008;294:1274-1281.
45. Sjaastad I, Sejersted OM, Ilebekk A, Bjornerheim R: Echocardiographic criteria for detection of postinfarction congestive heart failure in rats. J Appl Physiol 2000;89:1445-1454.
46. Janssen SP, Gayan-Ramirez G, Van den Bergh A, Herijgers P, Maes K, Verbeken E, Decramer M: Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 2005;111:996-1005.
47. Argiles JM, Busquets S, Lopez-Soriano FJ: The pivotal role of cytokines in muscle wasting during cancer. Int J Biochem Cell Biol 2005;37:2036-2046.
48. Cheema IR, Hermann C, Postell S, Barnes P: Effect of chronic excess of tumour necrosis factor-alpha on contractile proteins in rat skeletal muscle. Cytobios 2000;103:169-176.
49. Li X, Moody MR, Engel D, Walker S, Clubb FJ, Sivasubramanian N, Mann DL, Reid MB: Cardiac-specific overexpression of tumor necrosis factor-alfa causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 2000;102:1690-1696.
50. Gosselin LE, Barkley JE, Spencer MJ, McCormick KM, Farkas GA: Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion. Muscle Nerve 2003;28:336-343.
51. Camps M, Nichols A, Arkinstall S: Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 1999;14:6-16.
52. Osorio-Fuentealba C, Valdés JA, Riquelme D, Hidalgo J, Hidalgo C, Carrasco MA: Hypoxia stimulates via separate pathways ERK phosphorylation and NF-kappaB activation in skeletal muscle cells in primary culture. J Appl Physiol 2009;106:1301-1310.
53. Vary TC, Deiter G, Lang CH: Diminished ERK 1/2 and p38 MAPK phosphorylation in skeletal muscle during sepsis. Shock 2004;22:548-554.
54. Haddad F, Adams GR: Inhibition of MAP/ERK kinase prevents IGF-1 induced hypertrophy in rat muscles. J Appl Physiol 2004;96:203-210.
55. Toth MJ, Ades PA, LeWinter MM, Tracy RP, Tchernof A: Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones. J Appl Physiol 2006;100:35-41.
56. Anker SD, Volterrani M, Pflaum CD, Strasburger CJ, Osterziel KJ, Doehner W, Ranke MB, Poole-Wilson PA, Giustina A, Dietz R, Coats AJS: Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 2001;38:443-452.
57. Wu JJ, Roth RJ, Anderson EJ, Hong EG, Lee MK, Choi CS, Neufer PD, Shulman GI, Kim JK, Bennett AM: Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 2006;4:61-73.
58. Jamaluddin M, Wang S, Boldogh I, Tian B, Brasier AR: TNF-alpha-induced NF-kappaB/RelA Ser276 phosphorylation and enhanceosome formation is mediated by an ROS-dependente PKAc pathway. Cell Signal 2007;19:1419-1433.
59. Ekmark M, Gronevik E, Schjerling P, Gundersen K: Myogenin induces higher oxidative capacity in pre-existing mouse muscle fibres after somatic DNA transfer. J Physiol 2003;548:259-269.
60. Loughna PT, Brownson C: Two myogenic regulatory factor transcripts exhibit muscle-specific responses to disuse and passive stretch in adult rats. FEBS Letter 1996;390:304-306.
61. Smith CK, Janney MJ, Allen RE: Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J Cell Physiol 1994;159:379-385.
62. Chargé SBP, Rudnicki MA: Cellular and molecular of muscle regeneration. Physiol Rev 2004;84:209-238.